Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules.
Lai Y, Wang Y, Wu Y, Wu M, Xing S, Xie Y, Chen S, Li X, Zhang A, He Y, Li H, Dai S, Wang J, Lin S, Bai Y, Du H, Liu W.
Lai Y, et al. Among authors: li x, li h.
Cancer Control. 2022 Jan-Dec;29:10732748221104661. doi: 10.1177/10732748221104661.
Cancer Control. 2022.
PMID: 35653624
Free PMC article.